| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 02/25/2004 | CN1478085A ABCA-1 elevating compounds against coronary artery disease or atherosclerosis |
| 02/25/2004 | CN1478078A Nitrogenous aromatic ring compounds |
| 02/25/2004 | CN1478076A MCH antagonists and their use in treatment of obesity |
| 02/25/2004 | CN1477960A EPA receptor inhibitors to treat rheumatoid arthritis |
| 02/25/2004 | CN1139627C Phenol-free stabilization of polyolefin fibres |
| 02/25/2004 | CN1139577C Improved process for preparation of unsymmetrical 4,6-bis(aryloxy) pyrimidine compounds |
| 02/24/2004 | US6696475 Substituted phenyl derivatives, their preparation and use |
| 02/24/2004 | US6696471 Aminopyrrole compounds |
| 02/24/2004 | US6696469 For treatment of diseases or pathological conditions in which endothelial dysfunction is known; atherosclerosis, dyslipidaemia, diabetes |
| 02/24/2004 | US6696467 Quinoline derivatives |
| 02/24/2004 | US6696459 Using high affinity, high selectivity quinoline derivativesw |
| 02/24/2004 | US6696456 Carbocyclic acids and salts such as (2s,3r)-3-ethylsulfanyl-2-(4'-fluoro-biphenyl-4-sulfonylamino)-3- phenylpropionic acid, used as metalloenzyme antagonists for the prophylaxis of degenerative joint disease and as wound healing agents |
| 02/24/2004 | US6696452 Glycogen synthase kinase-3 and aurora-2 a serine/threonine protein kinase inhibitors; antidiabetic and anticancer agents and alzheimer's disease treatments |
| 02/24/2004 | US6696451 Dihydropyrimidines |
| 02/24/2004 | US6696449 Control degradation of conencting tissue; cardiovascular disorders |
| 02/24/2004 | US6696447 Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain |
| 02/24/2004 | US6696443 Piperidine/piperazine-type inhibitors of p38 kinase |
| 02/24/2004 | US6696438 Cyclic amino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds |
| 02/24/2004 | US6696437 Polymerase inhibitors comprising heterocyclic amides such as 2-pyridin-2-ylbenzimidazole-4-carboxamide, used for prophylaxis of neurodegenerative disorders, damage to hearts or brains, and as anticarcinogenic agents |
| 02/24/2004 | US6696418 Somatostatin antagonists and agonists that act at the SST subtype 2 receptor |
| 02/19/2004 | WO2004014916A1 Pyrimidine fused bicyclic metalloproteinase inhibitors |
| 02/19/2004 | WO2004014900A1 Benzimidazoles and benzothiazoles as inhibitors of map kinase |
| 02/19/2004 | WO2004014894A1 Novel prodrugs of 1-methyl-2(4-amidinophenylaminomethyl)-benzimidazol-5-yl-carboxylic acid-(n-2-pyridil-n-2-hydroxycarbonylethyl)-amide, production and use thereof as medicaments |
| 02/19/2004 | WO2004014893A2 Antimicrobial aza-bicyclic derivates, their compositions and uses |
| 02/19/2004 | WO2004014892A1 Monocyclic derivatives as matrix metalloproteinase inhibitors |
| 02/19/2004 | WO2004014891A1 Pyridazine derivatives as ligands for gaba receptors |
| 02/19/2004 | WO2004014878A1 1,2,4-triazole derivative, method for preparing the same, and pharmaceutical composition containing the same |
| 02/19/2004 | WO2004014871A1 Vanilloid receptor ligands and their use in treatments |
| 02/19/2004 | WO2004014870A1 Fluorinated phenyl-naphthalenyl-urea compounds as inhibitors of cytokines involved in inflammatory processes |
| 02/19/2004 | WO2004014869A2 5,6-fused 3,4-dihydropyrimidine-2-one derivatives as matrix metalloproteinase inhibitors |
| 02/19/2004 | WO2004014868A2 Pyrimidine-2,4-dione derivatives as matrix metalloproteinase inhibitors |
| 02/19/2004 | WO2004014865A1 Phenylpyridazine derivatives as ligands for gaba receptors |
| 02/19/2004 | WO2004014864A1 1h-indazole-3-carboxamide compounds as cyclin dependent kinases (cdk) inhibitors |
| 02/19/2004 | WO2004014860A2 Fused heterocyclic compounds as peptidase inhibitors |
| 02/19/2004 | WO2004014859A2 Process for preparing quinolin antibiotic intermediates |
| 02/19/2004 | WO2004014854A1 3-imino-2-indolones for the treatment of depression and/or anxiety |
| 02/19/2004 | WO2004014851A2 Tyrosine kinase inhibitors |
| 02/19/2004 | WO2004014844A2 Aryl and heteroaryl compounds and methods to modulate coagulation |
| 02/19/2004 | WO2004014842A1 Acylated arylcycloalkylamines and their use as pharmaceuticals |
| 02/19/2004 | WO2004014430A1 Compositions of a cyclooxygenase-2 selective inhibitor and a carbonic anhydrase inhibitor for the treatment of neoplasia |
| 02/19/2004 | WO2004014389A1 3,4-dihydroquinolin-2-one, 5,6-fused oxazin-3-one, and 5,6-fused thiazin-3-one derivatives as matrix metalloproteinase inhibitors |
| 02/19/2004 | WO2004014379A1 Isoquinoline derivatives as matrix metalloproteinase inhibitors |
| 02/19/2004 | WO2004014378A1 3-isoquinolinone derivatives as matrix metalloproteinase inhiitors |
| 02/19/2004 | WO2004014377A1 4-hydroxyquinoline derivatives as matrix metalloproteinase inhibitors |
| 02/19/2004 | WO2004014372A1 Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals |
| 02/19/2004 | WO2004014369A1 Acylamino-substituted heteroaromatic compounds and their use as pharmaceuticals |
| 02/19/2004 | WO2004014368A1 3-pyrrolyl-pyridopyrazoles and 3-pyrrolyl-indazoles as novel kinase inhibitors |
| 02/19/2004 | WO2004014366A1 Hetero biaryl derivatives as matrix metalloproteinase inhibitors |
| 02/19/2004 | WO2004014365A1 Phthalimide derivatives as matrix metalloproteinase inhibitors |
| 02/19/2004 | WO2004014352A2 Methods for treating carbonic anhydrase mediated disorders |
| 02/19/2004 | WO2004014316A2 Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases |
| 02/19/2004 | WO2004014309A2 Improved process for hydroxyazapirones |
| 02/19/2004 | WO2004014300A2 Tyrosine kinase inhibitors |
| 02/19/2004 | WO2004007481A3 Substituted amine derivatives and methods of use in the treatment of angiogenesis relates disorders |
| 02/19/2004 | WO2004007478A3 Derivatives of 3-guanidinocarbonyl-1-heteroaryl-pyrrole, process for their preparation and their pharmaceutical use |
| 02/19/2004 | WO2003082190A3 Spirocyclic amides as cannabinoid receptor modulators |
| 02/19/2004 | WO2003065989A3 (oxime)carbamoyl fatty acid amide hydrolase inhibitors |
| 02/19/2004 | WO2003057213A3 Cyclohexano- and cycloheptapyrazole derivative compounds, for use in diseases associated with the 5-ht2c receptor |
| 02/19/2004 | WO2003037252A3 Tyrosine kinase inhibitors |
| 02/19/2004 | WO2002080869A3 Novel dyeing composition for dyeing keratinous fibres comprising a particular dicationic monoazo dye |
| 02/19/2004 | US20040034234 Adding sulfur dioxide to a mixture containing a cyanopyrazole 4-yl disulfide compound, a formate salt, trifluoromethyl bromide and a polar solvent to form 4-trifluoromethylthiopyrazole compound |
| 02/19/2004 | US20040034229 3,4-Di-substituted maleimide compounds as CXC chemokine receptor antagonists |
| 02/19/2004 | US20040034221 Enzyme inhibitors for treating AIDS |
| 02/19/2004 | US20040034089 Such as (1-((2,3-dihydro-2-(4-propyl-1H-imidazol-2-yl)-1H-indol-1 -yl)carbonyl)propyl)-carbamate; for inactivation of cholecystokinins |
| 02/19/2004 | US20040034084 Side effect reduction; for treatment of AIDS, cancer and arthritis |
| 02/19/2004 | US20040034081 Estrogen receptor modulators |
| 02/19/2004 | US20040034076 Such as methyl-3-azido-2-((4,6-dimethoxy-2-pyrimidinyl)oxy) 3,3-diphenylpropionate; for treatment of high blood pressure |
| 02/19/2004 | US20040034064 2-(biarylalkyl)amino-3-(alkanoylamino)pyridine derivatives |
| 02/19/2004 | US20040034063 Antiallergens for treating and prevention of asthma |
| 02/19/2004 | US20040034061 An antagonist of corticotropin releasing factor receptor, treating depression, anxiety, Alzheimer's disease, Parkinson's disease, Huntington's chorea, eating disorder, hypertension, gastrointestinal disorders, drug dependence |
| 02/19/2004 | US20040034048 Didepsipeptide-based endoparasiticides, new didepsipeptides and process for preparing the same |
| 02/19/2004 | US20040034047 E.g. 5-(6,7-dimethoxy-2-(4-methoxybenzyl)benzofuran-4-yl-methyl-)pyrimidine-2,4 -diamine; bactericides for infections of grampositive and gramnegative pathogens; more potent than Trimethoprim, especially against respiratory tract pathogens |
| 02/19/2004 | US20040034044 Quinazoline derivatives and drugs |
| 02/19/2004 | US20040034037 Heteroaryl compounds useful as inhibitors of GSK-3 |
| 02/19/2004 | US20040034035 Calcium channel inhibitors comprising benzhydril spaced from piperazine |
| 02/19/2004 | US20040034034 Novel piperazine derivatives |
| 02/19/2004 | US20040034032 Quinoline and quinazoline compounds useful in therapy |
| 02/19/2004 | US20040034031 3,4-Disubstituted, 3,5-disubstituted and 3,4,5-substituted piperidines |
| 02/19/2004 | US20040034028 4-(biphenylcarbonylamino)piperidine derivatives as mtp inhibitors |
| 02/19/2004 | US20040034025 Having a high residual activity, greater activity at lower application rates, curative activity, and a broader spectrum of efficacy; heterocyclic aromatic amides having a hydroxy group adjacent to the amide functionality |
| 02/19/2004 | US20040034019 Piperazine and piperidine derivatives |
| 02/19/2004 | US20040034018 2-amino-trihydroindole or tetrahydronapthalene-2-yl derivatives, useful for disease state associated with smooth muscle disorders, such as gastrointestinal and urogenital disorders |
| 02/19/2004 | US20040034008 N-alkylpiperdino-4-yl-urea-pyrazole derivative for treating obesity, metabolic disorders, eating disorders and diabetes |
| 02/19/2004 | DE10236340A1 New heteroar(alkan)oyl-substituted phenyl-beta-alaninamide derivatives, useful as broad-spectrum antibacterial agents in human or veterinary medicine |
| 02/19/2004 | DE10235690A1 New N-benzyl-anthranilic acid (hetero)arylamide derivatives and analogs, are tyrosine kinase KDR and FLT inhibitors and angiogenesis inhibitors, useful e.g. for treating tumors, psoriasis or restenosis |
| 02/19/2004 | DE10235639A1 New prodrugs of benzimidazole-5-carboxamide derivative thrombin inhibitor, useful for treating or preventing thrombotic diseases, are well tolerated on subcutaneous injection |
| 02/19/2004 | CA2497656A1 Pyrimidine-2,4-dione derivatives as matrix metalloproteinase inhibitors |
| 02/19/2004 | CA2495659A1 Process for hydroxyazapirones |
| 02/19/2004 | CA2495516A1 Compositions of a cyclooxygenase-2 selective inhibitor and a carbonic anhydrase inhibitor for the treatment of neoplasia |
| 02/19/2004 | CA2495502A1 Methods for treating carbonic anhydrase mediated disorders |
| 02/19/2004 | CA2495285A1 Phenylpyridazine derivatives as ligands for gaba receptors |
| 02/19/2004 | CA2495266A1 Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases |
| 02/19/2004 | CA2495216A1 3-pyrrolyl-pyridopyrazoles and 3-pyrrolyl-indazoles as novel kinase inhibitors |
| 02/19/2004 | CA2494824A1 Fluorinated phenyl-naphthalenyl-urea compounds as inhibitors of cytokines involved in inflammatory processes |
| 02/19/2004 | CA2494298A1 Acylamino-substituted heteroaromatic compounds and their use as pharmaceuticals |
| 02/19/2004 | CA2494048A1 4-hydroxyquinoline derivatives as matrix metalloproteinase inhibitors |
| 02/19/2004 | CA2494014A1 Monocyclic derivatives as matrix metalloproteinase inhibitors |
| 02/19/2004 | CA2493660A1 Process for preparing quinolin antibiotic intermediates |
| 02/19/2004 | CA2493575A1 Tyrosine kinase inhibitors |
| 02/19/2004 | CA2493146A1 Antimicrobial aza-bicyclic derivates, their compositions and uses |